Table S9 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer

Table S9 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer

<p>Table S9: Results of ATAC-seq of primary and TONSL-immortalized cells.</p>

-д хадгалсан:

Номзүйн дэлгэрэнгүй
Үндсэн зохиолч:	Aditi S. Khatpe (15293176) (author)
Бусад зохиолчид:	Rebecca Dirks (15293179) (author), Poornima Bhat-Nakshatri (15293182) (author), Henry Mang (15293185) (author), Katie Batic (15293188) (author), Sarah Swiezy (15293191) (author), Jacob Olson (15293194) (author), Xi Rao (15293197) (author), Yue Wang (15293200) (author), Hiromi Tanaka (15293203) (author), Sheng Liu (15293206) (author), Jun Wan (15090186) (author), Duojiao Chen (15293209) (author), Yunlong Liu (15293212) (author), Fang Fang (14946450) (author), Sandra Althouse (15293215) (author), Emily Hulsey (15293218) (author), Maggie M. Granatir (15293221) (author), Rebekah Addison (15293224) (author), Constance J. Temm (15293227) (author), George Sandusky (15293230) (author), Audrey Lee-Gosselin (15293233) (author), Kenneth Nephew (15293236) (author), Kathy D. Miller (15045080) (author), Harikrishna Nakshatri (14946969) (author)
Хэвлэсэн:	2025
Нөхцлүүд:	Cancer Cancer Biology Molecular and Cellular Biology Therapeutic Research and Development Breast Cancer Carcinogenesis DNA Damage and Repair Small Molecule Agents
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!

Ижил төстэй зүйлс

Table S1 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
-н: Aditi S. Khatpe (15293176)
Хэвлэсэн: (2025)

Table S10 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
-н: Aditi S. Khatpe (15293176)
Хэвлэсэн: (2025)

Table S11 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
-н: Aditi S. Khatpe (15293176)
Хэвлэсэн: (2025)

Table S12 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
-н: Aditi S. Khatpe (15293176)
Хэвлэсэн: (2025)

Table S13 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
-н: Aditi S. Khatpe (15293176)
Хэвлэсэн: (2025)

Table S14 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
-н: Aditi S. Khatpe (15293176)
Хэвлэсэн: (2025)

Table S15 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
-н: Aditi S. Khatpe (15293176)
Хэвлэсэн: (2025)

Table S2 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
-н: Aditi S. Khatpe (15293176)
Хэвлэсэн: (2025)

Table S3 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
-н: Aditi S. Khatpe (15293176)
Хэвлэсэн: (2025)

Table S4 from TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
-н: Aditi S. Khatpe (15293176)
Хэвлэсэн: (2025)

Supplementary Figure S9 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Table S9 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Figure S1 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Figure S10 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Figure S11 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Figure S12 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Figure S13 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Figure S14 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Figure S15 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Figure S16 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Figure S17 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Figure S18 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Figure S19 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Figure S2 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Figure S20 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Figure S21 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Figure S3 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Figure S4 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Figure S5 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Figure S6 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Figure S7 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Figure S8 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Table S1 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Table S10 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Table S11 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Table S12 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Table S13 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Table S2 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Table S3 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Supplementary Table S4 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
-н: Chuandong Geng (17315310)
Хэвлэсэн: (2025)

Cannot write session to /tmp/vufind_sessions/sess_g0n8qpeg2fquv9i9i4v91sc5pq